Filter
760
Filtered Results: 760
Text search:
antígenos
Featured
Recommendations
76
New Publications
163
Language
Document type
No document type
350
Guidelines
217
Studies & Reports
81
Manuals
49
Strategic & Response Plan
23
Fact sheets
16
Situation Updates
10
Training Material
7
Brochures
2
Infographics
2
Videos
2
Resource Platforms
1
Countries / Regions
Brazil
51
India
39
Latin America and the Carribbean
33
Argentina
26
Global
23
Colombia
16
Kenya
16
Paraguay
16
Germany
15
Africa
13
Uganda
12
Tanzania
11
Bolivia
11
South Africa
10
El Salvador
9
Nigeria
9
Peru
9
Mozambique
9
East and Southern Africa
9
Ecuador
9
Nepal
8
Liberia
8
Chile
7
Philippines
7
Ethiopia
7
Sierra Leone
6
Rwanda
6
West and Central Africa
6
Western and Central Europe
6
Malawi
5
Venezuela
5
Bangladesh
5
Zimbabwe
4
Middle East and North Africa
4
South–East Asia Region
4
Angola
4
Ukraine
3
Lesotho
3
Ghana
3
USA
3
Cambodia
3
Congo, Democratic Republic of
3
Namibia
3
Botswana
3
Zambia
3
Myanmar / Burma
3
Cameroon
2
North America
2
Spain
2
South Sudan
2
Pakistan
2
Guatemala
2
Timor Leste/ East Timor
1
Mexico
1
Syria
1
Senegal
1
Burkina Faso
1
Afghanistan
1
Guinea
1
Dominican Republic
1
Guinea-Bissau
1
Western Pacific Region
1
United Kingdom
1
Portugal
1
Nicaragua
1
Sri Lanka
1
Russia
1
Sudan
1
Honduras
1
Indonesia
1
Somalia
1
Cuba
1
Authors & Publishers
Publication Years
Category
Guidelines
145
COVID-19
107
Policies & Guidelines HIV & TB
70
Policies
46
Studies & Reports
30
Women & Child Health
21
TB
17
Vaccine-preventable Diseases
16
Drugs & Medical Equipment
15
Statistics
14
HIV & STI
14
Disease Prevention & Control
13
Capacity Building
12
Hepatitis
11
Immunization
11
Parasitology
11
Pediatrics
10
Chagas
10
Demograhic Health Surveys DHS
10
Virology
9
Malaria
9
General Guidelines
8
Communicable Diseases
7
Leishmaniasis
6
Bacteriology
5
Medical Devices & Equipment
5
Humanitarian Crisis
5
NTDs & Others
5
Yellow Fever
4
Dengue
4
Paediatrics
3
Rabies
3
Hematology
3
Community Health
3
General Guidelines
3
Health Systems
3
Schistosomiasis
2
Dermatology
2
Vector Control
2
Monitoring & Evaluation
2
Maternal & Child Health
2
Countries
2
Diarrhoeal Disease/Cholera
2
Quality Control & Assurance
2
Leprosy
2
Maternal Health
2
Age & Elderly
2
Neonatal Care
2
Dental & Eye Care
1
Clinical Training
1
Helminthiasis
1
Lymphaticfilariasis
1
Humanitarian Aid
1
Cancer
1
Community Health
1
Pediatric cancer
1
Infection Control & Prevention (IPC)
1
Public Health
1
Snakebites
1
Yersinia pestis (Plague)
1
NCD
1
Hemorrhagic Fever
1
Clinical Guidelines
1
Other
1
Respiratory Infections
1
Communicable Diseases
1
Needs Assessment
1
Women & Child Health
1
Non-communicable Diseases
1
Laboratory Quality Assurance
1
Pharmacy & Technologies
1
Toolboxes
Country specific documents
70
Diagnostics & Laboratory Guidance
31
Clinical Guidelines
20
Detection & Diagnosis
18
Laboratory
17
Prevention & Control
15
Testing Guidelines
15
Surveillance & Contact tracing
8
Vaccines & Immunization
7
Adults
7
Children
7
Research & Access
7
Surveillance
6
Opportunistic Infections
6
Public Health
6
Hospital Readiness/Essential Health Services
6
Immunization Guidelines
6
Argentina
6
Neurological Disorders
6
TB & Prisoners
6
Clinical Aspects, Treatment & Prevention
5
Treatment & Prevention
5
IACAPAP International Association for Child and Adolescent Psychiatry and Allied Professions
5
Children/Adolescents Mental Disorders
5
Prevention & Preparedness
5
Biontech/Pfizer Comirnaty
5
Studies & Reports
5
Studies & Reports
5
Co-Morbidities (except TB)
5
Action Plans, Policies & Response
5
Neurological disorders, Others
5
Clinical Aspects
4
Influenza Prevention & Control
4
Vaccination
4
TB & Other Vulnerable Populations
4
Context & Facts, Travel Advice
4
Infection Control General
4
Paediatrics
4
Communication Material
4
Genomic sequencing
4
Moderna
4
Inactivated COVID-19 Vaccines
4
El Salvador
4
Essential Medicines
4
HIV &TB
4
Zoonoses
4
Chagas
4
Clinical Aspects & Diagnostics
4
Clinical Aspects & Diagnostics
4
Studies & Reports
4
Disease Prevention & Control
4
Training
4
TB/HIV Coinfection
4
Outbreak Prevention & Control
3
Policies & Strategies
3
Assessment & Studies
3
Meningitis Prevention & Control
3
Laboratory Guidance
3
Yellow Fever
3
Dengue
3
Treatment Guidelines HIV
3
COVID-19
3
Access & Strategy
3
TB/HIV
3
Long COVID/ Post-COVID Syndrome
3
Others
3
Community Health Workers CHW
3
Colombia
3
Chile
3
Other Countries
3
Essential Medicines & Devices Lists
3
Guidelines & Manuals
3
Clinical Aspects & Diagnostics
3
Clinical Aspects & Diagnostics
3
Clinical Aspects & Diagnostics
3
Clinical Aspects & Diagnostics
3
Studies & Reports
3
Overview, Studies & Reports
3
Access to treatment and laboratory
3
Postexposure Prophylaxis (PEP), Pre-Exposure Prophylaxis (PrEP)
3
Prophylactic Treatment
3
Germany
3
TB
3
Meningitis & Encephalitis
3
Childhood TB
2
TB & Drug Abuse
2
HIV testing & services
2
Yellow Fever Prevention & Control
2
HIV surveillance
2
Children & Adolescents
2
South Africa
2
Hepatitis
2
Laboratory
2
Sexually Transmitted Infections
2
Hepatitis
2
Vaccination
2
Clinical aspects
2
Laboratory & Sampling
2
Medical professionals
2
Communication & Training
2
General
2
Treatment Guidelines
2
Public Health
2
For Health Worker
2
Global Impact: Socio-economic, health services, TB & HIV
2
Prison & Detention
2
Tips & Best Practice Examples
2
COVID-19 Vaccination
2
Ebola Treatment Center
2
Fair Allocation & Ethical Aspects
2
SARS-CoV-2 Variants
2
Vaxzevria (Astra Zeneca)
2
Research & Pipeline
2
Latin America
2
Brazil
2
Quality Assurance
2
Leishmaniasis
2
Capacity Building & Resources
2
Information & Education Material (IEC)
2
Studies & Reports
2
Studies & Reports
2
Leptospirosis
2
Women
2
Clinical Guidelines
2
Drug resistant TB
2
Alzheimer's Disease & Dementia
2
General
2
National Emergency Response Plans
2
Dengue Prevention & Control
2
Latin America & the Carribean
2
Chikungunya Prevention & Control
2
Zika Prevention & Control
2
HIV service delivery
2
AmR (Region of Americas)
2
Antiretroviral Treatment ART
2
Reports & Studies Children HIV
2
Reports & Studies
2
Treatment & Clinical Management
2
Gender Aspects
1
Africa
1
Drugs
1
Health Systems
1
Gynaecology / Obstetrics
1
Biosafety
1
ART Drug Resistance
1
General Reports
1
Clinical Guidelines
1
Ebola Prevention & Control
1
Policies & Strategies
1
Country specific
1
Clinical Guidelines
1
Prevention Guidelines
1
Influenza
1
Transgender People
1
Public Health
1
Surveillance
1
HIV
1
El Niño
1
Others
1
TB
1
Mental Health
1
Cholera Prevention & Control
1
Latin America
1
Preparedness, Response & Risk Communication
1
Mozambique
1
Attention deficit hyperactivity disorder (ADHD)
1
Women's Mental Health
1
Manual & Leaflet
1
Sustainable Development Goals
1
Clinical Guidelines
1
Context & Facts
1
Infection Prevention & Hygiene
1
Essential List
1
Clinical Aspects
1
Poster & Infographics
1
Video & Audio
1
Risk Communication & Community Engagement
1
For General Public & Community
1
For Parents & Children
1
Training, others
1
Country Specific
1
For People with Disabilities
1
Appeals and Response Plans
1
For Older People
1
Child Protection
1
Scientific & Research Studies
1
Educational Settings
1
Workplace
1
Physical Distancing
1
LGBTI*
1
Infection Control & Prevention (IPC)
1
Essential Medicines & Medical Devices
1
Blood Supply
1
Vaccination & Strategy
1
Non-pharmaceutical interventions (NPIs)
1
Long-term Care Facilities
1
TB/COVID-19
1
COVAX Initiative
1
Vector-based Vacines General
1
Johnson & Johnson
1
Sputnik V
1
Covaxin
1
Handbooks & Manuals
1
Primary Care
1
Midwives
1
Nurses
1
Booster Doses
1
Ecuador
1
Urban health
1
Falsified & Substandard
1
Supply Chain & Store Management
1
Rational use of Medicine
1
General documents One Health
1
General Guidelines for Rational Use
1
Pharmacovigilance
1
Public Health
1
Infectious Diseases
1
General
1
MPOX - Monkeypox
1
MPOX -Monkeybox Prevention & Control
1
NTDs
1
Capacity Building & Resources
1
Capacity Building & Resources
1
Clinical Aspects & Diagnostics
1
Clinical Aspects & Diagnostics
1
Information & Education Material (IEC)
1
Statistics & Facts
1
Statistics & Facts
1
Statistics & Facts
1
Statistics & Facts
1
Studies & Reports
1
Studies & Reports
1
Studies & Reports
1
Prevention & Control
1
Information & Education Material (IEC)
1
NTDs General
1
Capacity Building & Resource platforms
1
Vector control
1
Mycetoma, Chromoblastomycosis & other deep mycosis
1
Taeniasis/Cysticercosis
1
Health Worker
1
General Information
1
Clinical Aspects & Diagnosis
1
General
1
Diagnosis
1
Policies and guidelines
1
Contact Tracing
1
Zika
1
Community Worker
1
Diarrhoea
1
Education of students & professionals
1
Nutrition
1
Prevention of mother-to-child transmission (PMTCT)
1
Clinical Guidelines
1
HIV / AIDS
1
Assessment
1
Clinical Guidelines
1
Others
1
Yellow Fever Situation Report
1
Laboratory
1
Context & Facts
1
HIV in Key Populations
1
Preparedness & Prevention
1
Laboratory & Diagnostics
1
Case Definitions
1
Kenya
1
Situation Reports, others
1
Situation Reports & Updates
1
SEAR (South-east Asia Region)
1
Eastern Europe and central Asia
1
Urban Health
1
Plague Prevention & Control
1
A new version is published in 2014
Guia de manejo clinico
Estas definiciones provisionales de los casos se han elaborado a fin de normalizar a nivel mundial la clasificación y notificación de los casos de enfermedad por el virus de Zika (ZIKV). Asimismo, la OMS está elaborando orientaciones con respecto a la vigilancia de la enfermedad.
PQDx 0018-010-00 WHO
PQDx PR
July/2016, version 3.0
PQDx 0198-071-00
WHO PQDx PR
April/2016, version 2.0
MMWR. Recommendations and Reports:
December 16, 2005 / 54(RR15);49-55
Guidelines for vaccination against COVID-19 for international travellers and aid workers (25 June 2021)
LAM test as a diagnostic aid in patients with HIV and suspected tuberculosis: technical guidelines
Cryptococcal disease, particularly cryptococcal meningitis is a significant cause of morbidity and mortality among people living with HIV with advanced HIV disease. It is estimated that it is responsible for nearly 19% of AIDS-related mortality, second only to tuberculosis. Rapid screening, diagnosi...
Epidemiology
Chagas disease (American trypanosomiasis) is caused by the protozoan parasite Trypanosoma cruzi, and transmitted to humans by infected triatomine bugs, and less commonly by transfusion, organ transplant, from mother to infant, and in rare instances, by ingestion of contaminated food or...
Chagas disease (American trypanosomiasis) is caused by the protozoan parasite Trypanosoma cruzi, and transmitted to humans by infected triatomine bugs, and less commonly by transfusion, organ transplant, from mother to infant, and in rare instances, by ingestion of contaminated food or drink.1-4 The...
Theodor Bilharz, a German professor of anatomy and chief of surgery at the Kasr El Ani Hospital of Cairo from 1850, first identified an infective organism, Distomum hematobium in 1851, which was renamed Schistosoma haematobium in 1858. It arose from a cestode worm, Hymenoleptis nana, lying in the sm...
Schistosomiasis is an acute and chronic parasitic disease caused by blood flukes (trematode
worms) of the genus Schistosoma. At least 249 million people required preventive treatment in
2012. Preventive treatment, which should be repeated over a number of years, will reduce and
prevent morbidity.
FIND and Standard Diagnostics (SD) have developed a lateral flow rapid diagnostic test (RDT) to screen for
T.b. gambiense HAT that is cheap and easy to use. The tests are packed individually and are stable at 40°C for
up to 25 months; they are performed on fresh blood obtained from a finger prick...
Leishmaniasis is a complex vector-borne disease involving in its transmission several species of protozoan parasites called Leishmania, a wide variety of animal reservoirs and phlebotomine sandflies vectors. Cutaneous Leishmaniasis (CL) is the most common form of the disease, and its clinical manife...
La serovigilancia es una herramienta que complementa los métodos tradicionales de salud pública para la vigilancia de las enfermedades transmisibles y proporciona información valiosa sobre la transmisión de enfermedades en los grupos de la población; por ejemplo, para detectar brechas en la inm...
This status report shows how far we have come—and how much further we must go—if we hope to meet the global commitments to end AIDS in children. It offers a snapshot of global progress and permits an early assessment of the impact of the Global Alliance’s work.
